JRCT ID: jRCT2071210008
Registered date:09/04/2021
A phase 1 mass balance study of [14C]TAS-205 in healthy volunteers
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Duchenne Muscular Dystrophy |
Date of first enrollment | 24/05/2021 |
Target sample size | 6 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Orally administer 80 mL of the liquid containing [14C]TAS-205 and TAS-205 on day 1. |
Outcome(s)
Primary Outcome | - Concentrations of total radioactivity in blood and plasma, plasma TAS-205 concentrations and the pharmacokinetics parameters of TAS-205 - Radioactivity excretion and excretion rate, cumulative excretion, cumulative excretion rate into urine and feces. - Radioactivity excretion and excretion rate, cumulative excretion, cumulative excretion rate in all excreta (urine and faeces). - Plasma, urinary, and fecal metabolite profiles of TAS-205 , and structural estimation. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | < 40age old |
Gender | Both |
Include criteria | (1) Healthy adult male subjects who provided written informed consent to participate in the study (2) Aged 20 years or older and younger than 40 years at the time of informed consent (3) Capable of oral intake. (4) Body weight of 50 kg or more and body mass index of 18.5 or more and less than 25.0 |
Exclude criteria | (1) Had current or previous hypersensitivity or allergy to drugs (2) Had current or previous drug abuse (including use of illicit drugs) or alcoholism (3) Had any concurrent disease (including symptoms and signs; however, diseases that do not affect evaluations in the study such as asymptomatic pollinosis and wart are excluded) (4) Consumed foods or beverages containing the St. John's Wort within 28 days before study drug administration (5) Had blood pressure, pulse rate, and body temperature meeting any of the following at screening: Systolic blood pressure: <90 mmHg or >=140 mmHg Diastolic blood pressure: <40 mmHg or >=90 mmHg Pulse rate: <40 beats per minute (bpm) or >=100 bpm Body temperature: 35.0 or >= 37.1 |
Related Information
Primary Sponsor | Nasermoaddeli Ali |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT04825431 |
Contact
Public contact | |
Name | Yoshitaka Takebe |
Address | 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo Tokyo Japan 101-8444 |
Telephone | +81-3-3293-2455 |
y-takebe@taiho.co.jp | |
Affiliation | Taiho Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | Ali Nasermoaddeli |
Address | 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo Tokyo Japan 101-8444 |
Telephone | +81-3-3293-2455 |
y-takebe@taiho.co.jp | |
Affiliation | Taiho Pharmaceutical Co., Ltd. |